{
    "nct_id": "NCT04743310",
    "official_title": "A Phase 2 Study of Fluorescence Detection of Adult Primary Central Nervous System Tumors in Subjects Receiving Tozuleristide and Imaged with the Canvas System",
    "inclusion_criteria": "* MRI obtained within 30 days of study enrollment documents a measurable lesion consistent with a primary malignant central nervous system tumor for which maximal safe resection is indicated OR MRI obtained within 30 days of study enrollment documents a measurable lesion consistent with a primary schwannoma enhancing tumor in the cerebellopontine angle for which maximal safe resection is indicated.\n* Adequate renal and liver function\n* Subjects with prior therapy are eligible provided they have recovered from any acute toxic effects of prior therapy and have sufficient time interval prior to enrollment.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Pregnant, breast-feeding, or planning to conceive a child within 30 days\n* Ongoing serious medical conditions such that participation in the study could put the subject at increased risk of worsening their condition\n* Subjects planned to undergo only a diagnostic biopsy procedure, without intent to resect tissue for therapeutic purposes\n* Subjects for whom radiographic evidence suggests a non-intra-axial primary brain tumor",
    "miscellaneous_criteria": ""
}